Profile data is unavailable for this security.
About the company
Curasight A/S is a clinical development company based in Copenhagen, Denmark. The Company is a pioneer in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR). The technology provides improved diagnosis and risk stratification in multiple cancer types.
- Revenue in DKK (TTM)-28.43m
- Net income in DKK-31.76m
- Incorporated2013
- Employees4.00
- LocationCurasight A/SOle Maaloees Vej 3, Koebenhavn NKOEBENHAVN 2200DenmarkDNK
- Websitehttps://www.curasight.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annexin Pharmaceuticals AB (publ) | 0.00 | -33.79m | 177.89m | 4.00 | -- | 11.01 | -- | -- | -0.1734 | -0.1734 | 0.00 | 0.0471 | 0.00 | -- | -- | 0.00 | -235.29 | -125.42 | -407.84 | -151.33 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -8.17 | -- | -- | -- |
| Bergenbio ASA | 330.45k | -98.57m | 180.06m | 15.00 | -- | 1.62 | -- | 544.89 | -5.37 | -5.37 | 0.018 | 4.48 | 0.0023 | -- | 0.0411 | 20,840.00 | -67.73 | -66.15 | -85.55 | -78.74 | -- | -- | -29,828.21 | -11,419.44 | -- | -- | 0.00 | -- | -9.00 | -31.43 | 36.98 | -- | -- | -- |
| Herantis Pharma Oyj | 0.00 | -4.57m | 187.99m | 11.00 | -- | 12.35 | 12.15 | -- | -0.0146 | -0.0146 | 0.00 | 0.1012 | 0.00 | -- | -- | 0.00 | -13.93 | -80.46 | -27.32 | -104.37 | -- | -- | -- | -- | -- | -- | 0.0145 | -- | -- | -- | 103.00 | -- | -- | -- |
| Xbrane Biopharma AB | 128.74m | -196.37m | 195.52m | 65.00 | -- | 1.17 | -- | 1.52 | -0.7304 | -0.9784 | 0.2266 | 0.1701 | 0.2309 | 0.4396 | 5.01 | 2,148,473.00 | -35.22 | -40.98 | -70.65 | -67.24 | 61.87 | -- | -152.53 | -364.40 | 0.8986 | -8.52 | 0.3957 | -- | 314.33 | 63.42 | -91.10 | -- | 60.02 | -- |
| Saniona AB | 16.03m | -52.71m | 200.77m | 22.00 | -- | 44.68 | -- | 12.53 | -0.9821 | -0.9821 | 0.2822 | 0.0623 | 0.2386 | -- | 6.23 | 1,081,652.00 | -78.47 | -59.16 | -168.78 | -70.15 | -92.01 | -970.05 | -328.83 | -1,483.55 | -- | -3.03 | 0.8668 | -- | 10.19 | -21.05 | 54.71 | -- | -34.94 | -- |
| Medivir AB | 4.47m | -75.34m | 200.92m | 10.00 | -- | 2.20 | -- | 44.98 | -1.42 | -1.42 | 0.0735 | 1.26 | 0.0365 | -- | 1.31 | 693,300.00 | -61.49 | -28.91 | -81.28 | -34.77 | -1,300.04 | -467.42 | -1,686.46 | -675.96 | -- | -- | 0.0628 | -- | 73.16 | -20.39 | -0.6275 | -- | -47.96 | -- |
| Hamlet BioPharma AB | 0.00 | -26.94m | 205.81m | 7.00 | -- | 6.51 | -- | -- | -0.2756 | -0.2756 | 0.00 | 0.3842 | 0.00 | -- | -- | 0.00 | -86.17 | -80.47 | -92.51 | -97.51 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -104.57 | -- | -- | -- |
| Oncopeptides AB | 17.44m | -181.95m | 208.85m | 79.00 | -- | 2.39 | -- | 11.97 | -1.94 | -1.94 | 0.1763 | 0.6421 | 0.0882 | 0.8441 | 0.6929 | 474,929.80 | -91.96 | -141.28 | -107.34 | -200.49 | 89.97 | -- | -1,043.16 | -2,689.06 | 6.16 | -199.53 | 0.5030 | -- | 321.54 | -- | 26.29 | -- | -- | -- |
| SynAct Pharma AB | 0.00 | -99.59m | 209.81m | 6.00 | -- | 1.92 | -- | -- | -4.25 | -4.25 | 0.00 | 4.10 | 0.00 | -- | -- | 0.00 | -62.70 | -125.17 | -70.31 | -151.70 | -- | -- | -- | -- | -- | -199.31 | 0.0084 | -- | -- | -- | -117.54 | -- | -- | -- |
| Lytix Biopharma AS | 9.16m | -48.49m | 214.59m | 10.00 | -- | 5.71 | -- | 23.43 | -1.83 | -1.83 | 0.3454 | 1.19 | 0.1563 | -- | 1.42 | 1,444,300.00 | -82.70 | -56.91 | -103.61 | -65.83 | -- | -- | -529.29 | -771.78 | -- | -- | 0.0482 | -- | -63.82 | 63.94 | -56.77 | -- | -- | -- |
| Alzinova AB | 193.30k | -11.67m | 214.87m | 5.00 | -- | 1.98 | -- | 1,111.60 | -0.332 | -0.332 | 0.0055 | 1.89 | 0.0025 | -- | 0.4752 | 60,000.00 | -15.15 | -10.77 | -15.91 | -11.27 | -2,621.00 | -- | -6,039.67 | -18,447.90 | -- | -392.89 | 0.0076 | -- | -- | -- | -25.92 | -- | 15.81 | -- |
| Thor Medical ASA | 0.00 | -11.77m | 223.44m | 1.00 | -- | 1.35 | -- | -- | -0.0873 | 0.021 | 0.00 | 1.11 | 0.00 | -- | -- | 0.00 | -9.82 | -79.17 | -10.54 | -113.94 | -- | -- | -- | -- | -- | -- | 0.0035 | -- | -- | -- | -- | -- | -- | -- |
| Cantargia AB | 0.00 | -146.88m | 223.57m | 23.00 | -- | 3.83 | -- | -- | -1.29 | -1.29 | 0.00 | 0.4932 | 0.00 | -- | -- | 0.00 | -98.38 | -55.08 | -129.99 | -61.35 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 24.69 | -- | -- | -- |
| Initiator Pharma A/S | 0.00 | -16.92m | 236.17m | 3.00 | -- | 13.21 | -- | -- | -0.4784 | -0.4784 | 0.00 | 0.5235 | 0.00 | -- | -- | 0.00 | -65.39 | -68.27 | -73.28 | -74.02 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 27.95 | -- | -- | -- |
| Curasight A/S | -28.43m | -31.76m | 247.00m | 4.00 | -- | 19.47 | -- | -- | -1.51 | -1.51 | -1.35 | 0.6008 | -0.7563 | -- | -- | -7,107,500.00 | -84.49 | -24.61 | -111.31 | -26.01 | -- | -- | -- | -- | -- | -32.26 | 0.4439 | -- | -123.97 | -- | -42.62 | -- | -- | -- |
| Mendus AB (publ) | 0.00 | -91.12m | 308.26m | 28.00 | -- | 0.685 | -- | -- | -3.54 | -3.54 | 0.00 | 13.87 | 0.00 | -- | -- | 0.00 | -21.08 | -18.84 | -23.01 | -20.21 | -- | -- | -- | -28,474.53 | -- | -- | 0.0318 | -- | -100.00 | -- | 26.78 | -- | -- | -- |
Data as of Nov 12 2024. Currency figures normalised to Curasight A/S's reporting currency: Danish Krone DKK
